|
PALI | Palisade Bio, Inc. |
|
|
PALI | Palisade Bio, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 21.26 |
| Leverage | 3.95% |
| Market Cap | $ 18.2m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -24.1m |
| Margin | -1027.40% |
Leading BioSciences, Inc. develops therapies to improve human health through therapeutic protection of the gastrointestinal mucosal barrier. The company is headquartered in Carlsbad, California.